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Purpose: Nonsyndromic autosomal recessive optic atrophy (arOA) is extremely rare and its existence was disputed until
a locus, optic atrophy 6 (OPA6), was mapped to 8q. Recently, a second locus, OPA7, was found on 11q in several families
from North Africa, with one presumably ancestral mutation of transmembrane protein 126A (TMEM126A). Here we report
an independently ascertained large consanguineous family of Moroccan descent with three siblings affected with
nonsyndromic arOA.
Methods: Assuming autosomal recessive inheritance, we identified a locus on 11q with homozygosity mapping, with a
multipoint logarithm of the odds score of 3.84, and sequenced two candidate genes. Direct sequencing of the complete
coding sequence of TMEM126A revealed mutation p.Arg55X, homozygous in all affected siblings and heterozygous in
both unaffected parents.
Results: This mutation was identical to that recently reported in families from North Africa, consistent with a single
ancestral origin. In contrast to the recently reported patients, however, the siblings reported in this study had a relatively
mild clinical course, with sudden onset in adolescence in the proband. Interestingly, the proband, but not the other affected
siblings, had sensory-motor axonal neuropathy with electrophysiological data strongly suggestive of focal demyelinating
abnormalities. An unaffected sibling had transient loss of vision after exercise, i.e., Uhthoff's sign of optic neuropathy,
and was found to be a heterozygous carrier of the mutation.
Conclusions: Our results confirm genetic heterogeneity in arOA, illustrate clinical variability between families with the
p.Arg55X mutation including the description of a mild phenotype in a heterozygote, and underscore the implication of
mitochondrial proteins in optic and peripheral neuropathy.
Optic atrophy (OPA) results from degeneration of the
retinal ganglion cells whose axons form the optic nerve.
Symptoms include a variable association of decreased visual
acuity, visual field defects, and color vision abnormalities.
The hallmark clinical sign is optic disc pallor. Optic nerve
damage is usually irreversible and often progressive. Bilateral
and symmetric forms of optic atrophy can be due to nutritional
(e.g., vitamin B12 or folate deficiency) and toxic insults or to
genetic defects [1]. Hereditary optic atrophies can be
autosomal dominant, autosomal recessive, X-linked
recessive, or maternal (mitochondrial DNA defects). In
nonsyndromic optic atrophies, optic nerve degeneration is the
only feature of the disease. In syndromic optic atrophies,
various neurologic and systemic abnormalities are present. All
nonsyndromic optic atrophies characterized to date result
from defects in genes encoding mitochondria-related proteins.
The most frequent forms of nonsyndromic optic atrophy are
autosomal dominant OPA1-linked OPA (OPA1, OMIM
165500, prevalence 1/50,000 in several populations [2]) and
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mitochondrial DNA-linked, maternally inherited Leber
hereditary optic neuropathy (LHON, OMIM 535000,
prevalence 1/25,000 in northeast England [3]). By contrast,
autosomal recessive forms of optic atrophy (arOA) are less
frequent, and most cases are syndromic (e.g., OPA3 or Type
III 3-methylglutaconic aciduria, Wolfram syndrome,
progressive encephalopathy with edema, hypsarrhythmia, and
optic atrophy syndrome). Isolated or nonsyndromic arOAs are
believed to be extremely rare. They are distinguished from
OPA1-linked optic neuropathy by the recessive pattern of
inheritance, an earlier age of onset (congenital or before age
3), and a generally more severe presentation (possibly
including nystagmus or severe dyschromatopsia) [4]. The first
locus for isolated arOA, OPA6 (OMIM 258500), has been
mapped to chromosome 8q21-q22 in a large multiplex
consanguineous family [4]. A second locus was reported on
chromosome 11q14.1-q21, and the recurrent nonsense
mutation p.Arg55X of transmembrane protein 126A
(TMEM126A) was shown to be present at homozygous state
in the affected patients of four different Maghrebian families
[5]. In another Algerian family, affected patients bearing the
homozygous p.Arg55X mutation in TMEM126A presented
with optic atrophy associated with auditory neuropathy [6].
Here we report a novel consanguineous family with arOA and
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peripheral neuropathy (in the proband only) but without
apparent auditory neuropathy, in which we demonstrate
linkage to the second reported locus on chromosome 11q14.1-
q21, OPA7 (OMIM 612989), and identify the recurrent
mutation p.Arg55X at homozygous state in TMEM126A in the
three affected patients.
METHODS
Proband and family: The proband, II:1, a 36-year-old man,
was the first child of consanguineous, half-first cousin parents
of Moroccan origin (Figure 1). At age 16, he presented with
sudden bilateral loss of visual acuity and dyschromatopsia.
Leber optic atrophy was suspected because of the brutal loss
of vision, although both eyes were simultaneously affected,
which is unusual in LHON. No nystagmus was noted. Eye
fundus examination, fluorescein angiography, visual field
testing, color vision analysis, optical coherence tomography
(OCT) scan of the retinal nerve fiber layers (RNFLs), and
standard electroretinogram were performed. Table 1
summarizes the clinical findings for the proband. His visual
acuity was <20/400 bilaterally (at age 16), the optic discs
showed bilateral pallor (Figure 2), the patient had an absolute
central scotoma bilaterally (Figure 3A) and severe
dyschromatopsia, the standard electroretinogram was normal,
and OCT showed thinning of all RNFL bundles (Figure 4A).
Fluorescein angiography failed to show the peripapillary
microvascular changes that are typical of the acute phase of
LHON. Homocysteine and vitamin B12 levels were normal in
the plasma. The profiles of organic and amino acids in the
urine were normal, including a normal level of
methylglutaconic acid. The proband had a neurologic
evaluation at age 33 years for bilateral weakness of foot
dorsiflexion with gait disturbance. Peripheral neuropathy was
suspected, and the symptoms improved with intravenous
immunoglobulin treatment. The cerebral computed
tomography scan was normal. Although the patient had no
more complaints, electrophysiological tests were conducted
at age 36. An important amplitude reduction was observed on
the tibial and sural nerves with conserved conduction
velocities and normal F-wave latencies evoking sensory-
motor axonal neuropathy. Temporal dispersions were
observed on the external popliteal sciatic nerves strongly
suggestive of focal demyelinating abnormalities. Two other
siblings, one brother, II:3, aged 30, and one sister, II:7, aged
20 (Figure 1), had had visual complaints since primary school,
bilateral mild decreased vision, temporal pallor of discs
(illustrated in Figure 2, lower, for sibling II:3), relative
scotoma in the papillomacular area bilaterally (Figure 3B,C)
and dyschromatopsia confirmed with ophthalmological
evaluation (see Table 1 for details). The OCT scan of sibling
II:3 showed temporal thinning of RNFL bilaterally (Figure
4B). In contrast with the proband, II:1, for which the disease
occurred abruptly and the visual loss was severe and did not
progress, the disease progressed slowly in the two siblings.
The parents and four other children underwent extensive
ophthalmological evaluation, and neither signs nor symptoms
of optic neuropathy were found. In another brother, II:4,
however, mild symptoms were noted, consisting of transient
Figure 1. Pedigree of the large
consanguineous Moroccan OPA7
family with haplotypes at the 11q13.5-
q14.2 region. The parents are half-first
cousins with one common ancestor. The
arrow indicates the proband. Black
symbols represent affected subjects, and
the gray symbol represents the brother
with Uhthoff’s phenomenon. The
homozygosity region is boxed. The
distance between D11S1321 and
D11S896 is 11.9 cM. The TMEM126A
position is indicated.
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partial visual loss after exercise (Uhthoff’s phenomenon),
without pallor of optic discs at funduscopy. Visual acuity was
normal (20/15) bilaterally, and color vision tests were normal
at age 28 (Table 1). The consanguinity of the asymptomatic
parents (half-first cousins with one common ancestor; Figure
1), the absence of symptoms in previous generations and the
fact that two males and one female were affected strongly
suggested autosomal recessive inheritance.
DNA extraction: Blood was drawn from peripheral vein with
informed consent from all family members. Samples were
conserved at room temperature before extraction. DNA was
extracted with a standard phenol-chloroform method. All
procedures followed the ethical guidelines of our institutions.
Our study was approved by the ethical committee of Hôpital
Erasme–ULB.
Mitochondrial DNA analysis: Mitochondrial DNA was
amplified to screen for mutations implicated in LHON in the
proband and his mother. Mutations of nucleotides 11778 (seen
in 40% to 90% of patients with LHON), 3460, 14484, and
15257 (seen in 50% of LHON 11778-negative patients), and
of the entire open reading frame of the mitochondrially
encoded nicotinamide adenine dinucleotide dehydrogenase 6
gene (MT-ND6; seen more rarely in patients with LHON)
were screened.
Linkage mapping: The microsatellites used to exclude the first
known locus for autosomal recessive OPA6 on chromosome
8q21-q22 were those described by Barbet et al. [4]. Genomic
TABLE 1. CLINICAL FINDINGS.
Patients Age (years) at onset Age (years) at visual
examination
VA RE VA LE Fundus
II.1 16 16 < 20/400 < 20/400 pale optic discs
II.3 primary school 22 20/60 20/60 temporal pallor of discs
II.4 28 20/15 20/15 normal
II.7 primary school 14 20/30 20/25 temporal pallor of discs
 Visual fields (Goldmann
perimetry)
ERG VEP OCT Ishihara plates
II.1 absolute central scotoma both eyes normal not done thinning of all
RNFL bundles
none detected
II.3 very small relative central scotoma not done not done temporal thinning
of RNFL
20 errors, deuteranopic type
II.4 normal not done not done not done no error
II.7 short arcuate defects near the blind
spot
not done not done not done none detected (but the first)
Figure 2. Eye fundi. The right eye (A)
and left eye (B) fundi of II:1 show pale
optic discs on both eyes. The right eye
(C) and left eye (D) fundi of II:3 show
temporal pallor of both dics.
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DNA of the three affected siblings was purified with the
QIAamp DNA purification kit (Qiagen, Germantown, MD).
DNA was hybridized on a 10K single nucleotide
polymorphism (SNP) microarray chip according to the Gene
Chip Human 10K array protocol by Affymetrix (Santa Clara,
CA). Results were analyzed for large regions of homozygosity
Figure 3. Visual fields. The right and left eye visual fields (Goldmann perimeter are represented for II:1 (A), II:3 (B), and II:7 (C).
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Figure 4. Optical coherence tomography (OCT) of the retinal nerve fiber layers (RNFLs). A: The right eye (upper) and left eye (lower) OCT
of RNFLs for II:1 show global thinning of all RNFLs. B: The right eye (upper) and left eye (lower) OCT of RNFLs for II:3 show temporal
thinning of RNFLs in both eyes.
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[7]. Microsatellite markers were then chosen according to the
SNP results for further linkage in all members of the family.
Multipoint linkage analysis was performed using the
MAPMAKER/HOMOZ algorithm software [8], under the
assumption of a fully penetrant disease with an allele
frequency of 0.001.
Candidate gene analysis: Specific primers were designed to
amplify and sequence candidate gene segments (primer
sequences used to amplify exon 3 of TMEM126A were 5′-TGT
CAA GAT CGG GAA AGC TC-3′ and 5′-TGC ATT ACA
GCA TAC AGC TAC TTG-3′ for a product size of 364 bp).
PCR products were purified and sequenced using the Big Dye
Terminator cycle sequencing kit v2 (Applied Biosystems,
Foster City, CA), and sequencing products were analyzed on
a 3100 Genetic Analyzer sequencing machine (Applied
Biosystems). The in silico mutation search was performed
using the SeqScape software version 2.0 (Applied
Biosystems).
RESULTS
Mitochondrial DNA analysis: We excluded mutations of
nucleotides 11778, 3460, 14484, and 15257 from
mitochondrial DNA in the proband and his mother. Mutations
of the MT-ND6 gene were also excluded in the second brother
affected, making LHON unlikely in this family.
Linkage mapping: We first excluded homozygosity for the
first known locus for autosomal recessive OPA6 on
chromosome 8q21-q22 [4] in the three affected subjects. We
did a genome-wide search for homozygosity-by-descent using
a 10K SNP array chip. In II:1, we found nine regions larger
than 5 Mb, three of which contained more than 500 SNPs
(Table 2). After the three affected subjects were compared,
only one large region of homozygosity of 10.8 Mb was
concordant, on chromosome 11 between rs2226615 and
rs2048973 (11q13.5–11q14.2). Further analysis of this
chromosomal segment in all members of the family using
microsatellite markers confirmed homozygosity in the three
affected subjects, and showed homozygosity for a portion of
this locus in brother II:4 with temporary partial visual loss
following exercise, making it difficult to determine his clinical
status (Figure 1 in gray). We did not find homozygosity in the
parents or in the unaffected siblings (Figure 1). Multipoint
linkage analysis with the MAPMAKER/HOMOZ algorithm
software provided a maximum multipoint logarithm of the
odds score of 3.84.
Candidate gene analysis: Forty-six genes were known or
annotated in the interval. A nuclear gene encoding a
mitochondrial protein, NDUFC2 (nicotinamide adenine
dinucleotide: ubiquinone oxidoreductase [complex I], the first
enzyme complex in the electron transport chain of
mitochondria), was considered an interesting candidate. We
analyzed this gene with direct sequencing using intronic
primers flanking each exon. No mutation was found.
TMEM126A was located in the interval, and a mutation of this
gene was reported in autosomal recessive optic atrophy [5]
during the course of our study. We sequenced TMEM126A in
our patients and found the same mutation, c.163C>T
(p.Arg55X; NM_032273), as previously reported in four
families from the Maghreb [5,6]. This mutation was
homozygous in the affected siblings (Figure 5A, proband),
heterozygous in the parents (Figure 5B, father), as well as in
the brother presenting temporary partial visual loss following
exercise (Figure 5C). This nonsense mutation was not found
in 100 controls of the same ethnic group (Figure 5D). We
genotyped 12 microsatellite markers surrounding
TMEM126A in the proband and compared the allele sizes
with the affected individuals described by Hanein et al. [5]
and Meyer et al. [6]. Interestingly, the two most closely linked
microsatellite markers, D11S1354 and D1SS1887, showed
only a small difference in allele size with the haplotype
reported by Hanein et al. [5], possibly due to inter-run
differences (Table 3).
DISCUSSION
The clinical picture of these three siblings showing optic
neuropathy involving the papillomacular bundles bilaterally
favors the diagnosis of a hereditary optic neuropathy.
The existence of isolated recessive OPA has long been
discussed, but in 2003 the first family with an unambiguous
autosomal recessive form was described in a large
consanguineous family of French origin, linked to a
TABLE 2. HOMOZYGOUS REGIONS OF MORE THAN 5 MB IN II.1
Homozygous
regions
Chromosome Length in
Mb
# SNPS SNP start Position start SNP stop Position stop
1 9 30 14 SNP_A-2078117 38736473 SNP_A-1812761 68741861
2 11 27.44 3374 SNP_A-4221532 76029213 SNP_A-2155922 103473380
3 1 23.36 20 SNP_A-2198638 1.2E+08 SNP_A-4238570 143576984
4 16 14.72 84 SNP_A-2303925 31767900 SNP_A-1835934 46484390
5 3 10.63 804 SNP_A-1831302 1.79E+08 SNP_A-1837638 189682173
6 2 9.71 979 SNP_A-2125652 2.18E+08 SNP_A-2021900 2.27785006
7 3 5.84 50 SNP_A-2143755 89819382 SNP_A-1841424 95661425
8 2 5.85 11 SNP_A-1932841 89750715 SNP_A-2108592 95603500
9 5 5.44 71 SNP_A-2213328 44662567 SNP_A-4210939 50098368
In the region indicated in bold, the TMEM126A gene was found
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chromosomal locus on 8q [4]. Our data confirm genetic
heterogeneity within arOAs: we report a large Moroccan
family with recessive OPA not linked to the 8q locus. Linkage
analysis in the large family reported here allowed us to
delineate a locus on chromosome 11q13.5-q14. All genes
involved in hereditary optic neuropathies known to date are
mitochondrial (LHON) or nuclear genes encoding proteins
with mitochondrial targeting (OPA1, OPA3) [9]. For this
reason, we initially screened the NDUFC2 gene but found no
mutation. Our linkage interval encompassed TMEM126A,
recently implicated in OPA7 [5]. TMEM126A encodes a
mitochondrial protein of higher eukaryotes with four
transmembrane domains and a central domain conserved with
TMEM126B [5]. Reverse transcriptase–PCR on total RNA
from various adult and fetal human tissues showed that
TMEM126A is strongly expressed in the brain (whole),
cerebellum, fetal brain, skeletal muscle, testis, fetal retinal
pigmentary epithelium, and fetal retina [5]. In situ
hybridization to the adult mouse retina at 8 months of age
detected significant levels of specific mRNA in the ganglion
cell layer, the optic nerve head, the outer plexiform layer, and
in the outer ellipsoid length of photoreceptor inner segments
[5]. Faint to no labeling was noted in the outer nuclear layer
and photoreceptor outer segments [5]. We confirmed the
implication of TMEM126A in the disease, showing the same
biallelic p.Arg55X mutation as the one recently described in
the four arOA families from the Maghreb [5]. In addition, as
the same mutation was recently identified in two siblings with
arOA and auditory neuropathy, originating from a
consanguineous Maghreb family [6], which prompted the
authors to postulate that TMEM126A could also be expressed
in inner hair cells. Our patients have no hearing complaints
but were not tested for auditory neuropathy. We genotyped
closely linked markers, assuming a founder mutation.
Although we could not obtain DNA samples from the
previously reported patients for comparison in the same
analysis, our results are possibly consistent with an ancestral
Maghreb mutation and either short tandem repeat increment
mutation or differences in calibration. Our study sustains the
importance of this gene in arOA. In addition, TMEM126A
might be an important candidate gene to screen in patients
with isolated nonsyndromic optic atrophy, especially in
juvenile forms and in patients of Maghrebian origin.
Unlike the patients previously reported with
TMEM126A-associated OPA7 [5,6], who presented with
onset during childhood (between age 4 and 6, and from birth,
respectively), and with a severe phenotype, the patients
described here presented with a later onset and milder form
Figure 5. TMEM126A sequence
profiles. A: The proband is homozygote
for the mutation c.163C>T (p.Arg55X).
B: The father is heterozygote for the
mutation. C: The brother presenting
transient partial visual loss following
exercise (Uhthoff’s phenomenon) is
heterozygote for the mutation. D: This
unrelated control subject has no
mutation.
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without apparent cardiac symptoms or hearing defect [6].
Furthermore, the proband in the present family presented with
an abrupt onset of symptoms initially thought to be consistent
with LHON. His two affected siblings had mild visual
problems in childhood but reported slowly progressing loss of
vision. Our patients were not tested for hypertrophic
cardiomyopathy, minor brain magnetic resonance imaging
alterations, or mild hearing loss [5], so these clinical features
may have been missed.
We noted sensory-motor axonal neuropathy with
electrophysiological data strongly suggestive of focal
demyelinating abnormalities in the proband. This phenotypic
association of peripheral neuropathy with optic atrophy is also
present in hereditary motor and sensory neuropathy type VI
with optic atrophy (OMIM 601152) caused by mutations in
mitofuscin 2 (MFN2) [10], encoding another mitochondrial
protein, emphasizing the important role of mitochondrial
function for optic atrophies and peripheral neuropathies.
Hanein et al. [5] overexpressed a TMEM126A-myc fusion
protein into COS-7 cells. Epitope-tagged wild-type
TMEM126A colocalized with mitochondrial complex II
subunit 70 kDa Fp (SDHA), complex IV subunit 1 (MTCO1),
ATP synthase subunit beta (ATP5B), and ATP synthase
subunit alpha (ATP5A), supporting the mitochondrial
localization of the protein. TMEM126A was suggested to be
a mitochondria-localized mRNA (MLR) protein and may be
essential in the early nucleation process of large mitochondrial
complexes [5]. Interestingly, patients affected with inborn
defects caused by mutations in the nuclear genes ATP
synthase mitochondrial F1 complex assembly factor 2
(ATPAF2), transmembrane protein 70 (TMEM70), or ATP
synthase, H+ transporting, mitochondrial F1 complex, epsilon
subunit (ATP5E) or in the mitochondrial genes ATP synthase
6, mitochondrial (MTATP6) or ATP synthase 8, mitochondrial
(MTATP8), encoding proteins of the mitochondrial complex
V (ATP synthase), whose subunits have also been shown to
be MLR proteins [11], present with neonatal-onset hypotonia,
lactic acidosis, hyperammonemia, hypertrophic
cardiomyopathy, 3-methylglutaconic aciduria, and in some
cases peripheral neuropathy [12].
We report the first observation of a heterozygous carrier
of the p.Arg55X mutation complaining of partial vision loss
following exercise (Uhthoff’s phenomenon), but displaying
no pallor of optic discs at funduscopy. Uhthoff's phenomenon
is typically associated with optic neuritis in multiple sclerosis
[13]. The relatively mild clinical course in our patients is
similar to the 8q-linked OPA6 reported in a French family
[4], but our patients had severe dyschromatopsia and bilateral
TABLE 3. ALLELES SIZES OF MICROSATELLITE MARKERS COMPARED TO MEYER ET AL. [6] AND HANEIN ET AL. [5].
 Proband, II.1 [6] [5]
Microsatellite size size-M13 Size F1 F2 F3 F4
D11S937 253,06 234,06 163
165
nd nd nd nd
D11S918 (AFM203vg1) 210,6 191,6 nd 183
191
197
nd nd nd
D11S4143 (AFMb055yd1) 226,16 207,16 nd 209
219
207 209 211
D11S1362 (AFMa132xh9) 219,35 200,35 nd 197 201 201 197
D11S2002 266,19 247,19 239 nd nd nd nd
D11S1396 187,06 168,06 152 nd nd nd nd
D11S901 (AFM063yg1) 192,93 173,93 310 160 168 176 160
D11S1354 (AFM338xe1) 193,94 174,94 nd 177 177 177 177
TMEM126A
D11S1887 (AFMa049wa5) 278,91 259,91 nd 263 263 263 263
D11S1780 (AFMa082wb9) 189,58 170,58 nd 189 191 173 173
D11S4176 (AFMb354xa5) 264,81 245,81 nd 230
214
224
nd nd nd
D11S4108 128,26 109,26 126 nd nd nd nd
        Overview of allele sizes of 12 microsatellites genotyped in the proband of this study and the affected individuals described in
        Meyer et al. [6] and Hanein et al. [5]. The size-M13 represents the allele size minus the length of the M13 tail used
        (CACGACGTTGTAAAACGAC). In bold underlined: founder haplotype described by Hanein et al. [5]. Abbreviations used:
        nd: no data; F: family.
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central scotoma. We conclude that the p.Arg55X mutation in
TMEM126A is probably ancestral in North African
populations. Homozygotes may present with an abrupt onset
of symptoms that mimic LHON or the course may be mild
with childhood or adolescent onset. Finally, Uhthoff’s
phenomenon might be a clue to the heterozygosity of the
mutation in unaffected family members.
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